Search Results - ASAI, Gyo

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

    Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study by Fukuhara, Tatsuro, Saito, Haruhiro, Furuya, Naoki, Watanabe, Kana, Sugawara, Shunichi, Iwasawa, Shunichiro, Tsunezuka, Yoshio, Yamaguchi, Ou, Okada, Prof Morihito, Yoshimori, Kozo, Nakachi, Ichiro, Gemma, Prof Akihiko, Azuma, Koichi, Kurimoto, Futoshi, Tsubata, Yukari, Fujita, Yuka, Nagashima, Hiromi, Asai, Gyo, Watanabe, Satoshi, Miyazaki, Masaki, Hagiwara, Prof Koichi, Nukiwa, Prof Toshihiro, Morita, Prof Satoshi, Kobayashi, Prof Kunihiko, Maemondo, Prof Makoto

    Published in EBioMedicine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial

    Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, rando... by Saito, Haruhiro, Fukuhara, Tatsuro, Furuya, Naoki, Watanabe, Kana, Sugawara, Shunichi, Iwasawa, Shunichiro, Tsunezuka, Yoshio, Yamaguchi, Ou, Okada, Morihito, Yoshimori, Kozo, Nakachi, Ichiro, Gemma, Akihiko, Azuma, Koichi, Kurimoto, Futoshi, Tsubata, Yukari, Fujita, Yuka, Nagashima, Hiromi, Asai, Gyo, Watanabe, Satoshi, Miyazaki, Masaki, Hagiwara, Koichi, Nukiwa, Toshihiro, Morita, Satoshi, Kobayashi, Kunihiko, Maemondo, Makoto

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Phase II Study of Weekly Paclitaxel for Relapsed and Refractory Small Cell Lung Cancer

    Phase II Study of Weekly Paclitaxel for Relapsed and Refractory Small Cell Lung Cancer by YAMAMOTO, Nobuyuki, TSURUTANI, Junji, YOSHIMURA, Naruo, ASAI, Gyo, MORIYAMA, Azusa, NAKAGAWA, Kazuhiko, KUDOH, Shinzo, TAKADA, Minoru, MINATO, Yoshiaki, FUKUOKA, Masahiro

    Published in Anticancer research
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Influence of histological type, smoking history and chemotherapy on survival after first‐line therapy in patients with advanced non‐small cell lung cancer

    Influence of histological type, smoking history and chemotherapy on survival after first‐line therapy in patients with advanced non‐small cell lung cancer by Itaya, Toru, Yamaoto, Nobuyuki, Ando, Masahiko, Ebisawa, Masako, Nakamura, Yukiko, Murakami, Haruyasu, Asai, Gyo, Endo, Masahiro, Takahashi, Toshiaki

    Published in Cancer science
    Request full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Balloon Dilatation of a Case of Tuberculous Tracheobronchial Stenoses during the Course of Antituberculous Treatment

    Balloon Dilatation of a Case of Tuberculous Tracheobronchial Stenoses during the Course of Antituberculous Treatment by Oki, Masahide, Ise, Yuko, Asai, Gyo, Saka, Hideo, Korrungruang, Potjanee, Nour Moursi Ahmed, Shimaa, Kitagawa, Chiyoe

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  6. 6
    Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer

    Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer by Asai, Gyo, Yamamoto, Nobuyuki, Kurata, Takayasu, Tamura, Kenji, Uejima, Hisao, Nakagawa, Kazuhiko, Fukuoka, Masahiro

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer

    Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer by ASAI, Gyo, YAMAMOTO, Nobuyuki, TOI, Masakazu, SHIN, Eisei, NISHIYAMA, Kiyoshi, SEKINE, Tomohisa, NOMURA, Yasuo, TAKASHIMA, Shigemitsu, KIMURA, Morihiko, TOMINAGA, Takeshi

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: